glp-1 drugs history Reflections on the discovery as a satiety hormone: Implications for obesity therapy and future directions Another milestone in the evolution
Description
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH (2009) Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

Brosseron F, Traschutz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, et al
Although GLP-1 clearly had therapeutic potential, s.c

2024;14(3):e077173

Given the increasing interest in the potential use of incretins in cardiovascular diseases, conducting randomized controlled trials in this direction is warranted
